226 related articles for article (PubMed ID: 24991322)
1. Chemotherapy-induced nausea and vomiting: optimizing prevention and management.
Rao KV; Faso A
Am Health Drug Benefits; 2012 Jul; 5(4):232-40. PubMed ID: 24991322
[TBL] [Abstract][Full Text] [Related]
2. Oncologist perspectives on chemotherapy-induced nausea and vomiting (CINV) management and outcomes: A quantitative market research-based survey.
Aapro M; Ruffo P; Panteri R; Costa S; Piovesana V
Cancer Rep (Hoboken); 2018 Dec; 1(4):e1127. PubMed ID: 32729252
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and cost: avoiding undertreatment of chemotherapy-induced nausea and vomiting.
Viale PH; Grande C; Moore S
Clin J Oncol Nurs; 2012 Aug; 16(4):E133-41. PubMed ID: 22842698
[TBL] [Abstract][Full Text] [Related]
4. Update on the management of chemotherapy-induced nausea and vomiting.
Viale PH
J Infus Nurs; 2006; 29(5):283-92. PubMed ID: 17035890
[TBL] [Abstract][Full Text] [Related]
5. Reviewing current and emerging antiemetics for chemotherapy-induced nausea and vomiting prophylaxis.
Natale JJ
Hosp Pract (1995); 2015; 43(4):226-34. PubMed ID: 26308912
[TBL] [Abstract][Full Text] [Related]
6. Antiemetic therapy options for chemotherapy-induced nausea and vomiting in breast cancer patients.
Chan VT; Yeo W
Breast Cancer (Dove Med Press); 2011 Nov; 3():151-60. PubMed ID: 24367184
[TBL] [Abstract][Full Text] [Related]
7. Chemotherapy-induced nausea and vomiting: incidence and characteristics of persistent symptoms and future directions NCCTG N08C3 (Alliance).
Kottschade L; Novotny P; Lyss A; Mazurczak M; Loprinzi C; Barton D
Support Care Cancer; 2016 Jun; 24(6):2661-7. PubMed ID: 26768436
[TBL] [Abstract][Full Text] [Related]
8. Testing the effectiveness of antiemetic guidelines: results of a prospective registry by the CINV Study Group of Japan.
Tamura K; Aiba K; Saeki T; Nakanishi Y; Kamura T; Baba H; Yoshida K; Yamamoto N; Kitagawa Y; Maehara Y; Shimokawa M; Hirata K; Kitajima M;
Int J Clin Oncol; 2015 Oct; 20(5):855-65. PubMed ID: 25681876
[TBL] [Abstract][Full Text] [Related]
9. The assessment and management of chemotherapy-induced nausea and vomiting among cancer patients in a chemotherapy ward: a best practice implementation project.
Gu L; Li J
JBI Database System Rev Implement Rep; 2016 Mar; 14(3):235-46. PubMed ID: 27532145
[TBL] [Abstract][Full Text] [Related]
10. Prevention and management of chemotherapy-induced nausea and vomiting.
Moradian S; Howell D
Int J Palliat Nurs; 2015 May; 21(5):216, 218-24. PubMed ID: 26107543
[TBL] [Abstract][Full Text] [Related]
11. Chemotherapy-induced nausea and vomiting in daily clinical practice: a community hospital-based study.
Hilarius DL; Kloeg PH; van der Wall E; van den Heuvel JJ; Gundy CM; Aaronson NK
Support Care Cancer; 2012 Jan; 20(1):107-17. PubMed ID: 21258948
[TBL] [Abstract][Full Text] [Related]
12. Practical management of chemotherapy-induced nausea and vomiting.
Wiser W; Berger A
Oncology (Williston Park); 2005 Apr; 19(5):637-45. PubMed ID: 15945344
[TBL] [Abstract][Full Text] [Related]
13. New and emerging therapeutic options for the management of chemotherapy-induced nausea and vomiting.
Schwartzberg LS; Rugo HS; Aapro MS
Clin Adv Hematol Oncol; 2015 Mar; 13(3 Suppl 3):3-13, 1; quiz 2 p following 14. PubMed ID: 25856052
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of clinical outcomes and efficacy of palonosetron and granisetron in combination with dexamethasone in Egyptian patients receiving highly emetogenic chemotherapy.
A Mahrous M; A El-Azab G; A Tawfik H
Cancer Chemother Pharmacol; 2021 Jul; 88(1):121-129. PubMed ID: 33835230
[TBL] [Abstract][Full Text] [Related]
15. Corticosteroids, the oldest agent in the prevention of chemotherapy-induced nausea and vomiting: What about the guidelines?
Van Ryckeghem F
J Transl Int Med; 2016 Apr; 4(1):46-51. PubMed ID: 28191518
[TBL] [Abstract][Full Text] [Related]
16. [Assessment of chemotherapy-induced nausea and vomiting(CINV)using MASCC antiemesis tool].
Yamaguchi M; Ogawa T; Watanabe M; Anami S; Kamigaki S; Nishikawa N; Ono T; Furukawa H
Gan To Kagaku Ryoho; 2009 Oct; 36(10):1691-6. PubMed ID: 19838029
[TBL] [Abstract][Full Text] [Related]
17. Professional educational needs for chemotherapy-induced nausea and vomiting (CINV): multinational survey results from 2388 health care providers.
Van Laar ES; Desai JM; Jatoi A
Support Care Cancer; 2015 Jan; 23(1):151-7. PubMed ID: 25015057
[TBL] [Abstract][Full Text] [Related]
18. Defining optimal control of chemotherapy-induced nausea and vomiting-based on patients' experience.
Hernandez Torres C; Mazzarello S; Ng T; Dranitsaris G; Hutton B; Smith S; Munro A; Jacobs C; Clemons M
Support Care Cancer; 2015 Nov; 23(11):3341-59. PubMed ID: 26108169
[TBL] [Abstract][Full Text] [Related]
19. Recent advances and updated guidelines in the management of chemotherapy-induced nausea and vomiting.
Schwartzberg LS; Grunberg SM; Kris MG
Clin Adv Hematol Oncol; 2011 Nov; 9(11 Suppl 27):1-14; quiz 15-6. PubMed ID: 22362372
[TBL] [Abstract][Full Text] [Related]
20. Guidelines versus individualized care for the management of CINV.
Clemons M
Support Care Cancer; 2018 Mar; 26(Suppl 1):11-17. PubMed ID: 29556809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
